The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
Open accessAbstract
Mucin 1 (MUC1) is a heterodimeric protein formed by two subunits that is aberrantly overexpressed in human breast cancer and other cancers. Historically, much of the early work on MUC1 focused on the shed mucin subunit. However, more recent studies have been directed at the transmembrane MUC1-C-terminal subunit (MUC1-C) that functions as an oncoprotein. MUC1-C interacts with EGFR (epidermal growth factor receptor), ErbB2 and other receptor tyrosine kinases at the cell membrane and contributes to activation of the PI3KAKT and mitogen-activated protein kinase kinase (MEK)extracellular signal-regulated kinase (ERK) pathways. MUC1-C also localizes to the nucleus where it activates the Wnt/β-catenin, signal transducer and activator of transcription (STAT) and NF (nuclear factor)-κB RelA pathways. These findings and the demonstration that MUC1-C is a druggable target have provided the experimental basis for designing agents that block MUC1-C function. Notably, inhibitors of the MUC1-C subunit have been developed that directly block its oncogenic function and induce death of breast cancer cells in vitro and in xenograft models. On the basis of these findings, a first-in-class MUC1-C inhibitor has entered phase I evaluation as a potential agent for the treatment of patients with breast cancers who express this oncoprotein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Targeting the phosphoinositide 3-kinase pathway in cancer
Liu, P., Cheng, H., Roberts, T. M., & Zhao, J. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2926 · Cited by 2,721
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Engelman, J. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2664 · Cited by 2,445
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Mucins in cancer: function, prognosis and therapy
Kufe, D. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2761 · Cited by 1,396
Self-citationSpecific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
The many ways of Wnt in cancer
Polakis, P. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.007 · Cited by 866
Gillett, C., Fantl, V., Smith, D., Fisher, C., Bartek, J. J., Dickson, C., Barnes, D. M., & Peters, G. (1994) · PubMed · Cited by 661
KUFE, D., INGHIRAMI, G., ABE, M., HAYES, D., JUSTI-WHEELER, H., & SCHLOM, J. (1984) · Hybridoma · doi:10.1089/hyb.1984.3.223 · Cited by 573
Self-citationGendler, S., Taylor-Papadimitriou, J., Duhig, T., Rothbard, J., & Burchell, J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37632-4 · Cited by 568
Cyclin D1 protein expression and function in human breast cancer
Bartkova, J., Lukas, J., Müller, H., Lützhøt, D., Strauss, M., & Bartek, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570311 · Cited by 509
A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer
Lamb, J., Ramaswamy, S., Ford, H. L., Contreras, B., Martinez, R. V., Kittrell, F. S., Zahnow, C. A., Patterson, N., Golub, T. R., & Ewen, M. E. (2003) · Cell · doi:10.1016/s0092-8674(03)00570-1 · Cited by 416
MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1
Sachdeva, M., & Mo, Y.-Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2021 · Cited by 394
Targeted therapies for breast cancer
Higgins, M. J., & Baselga, J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57152 · Cited by 369
Segregation of receptor and ligand regulates activation of epithelial growth factor receptor
Vermeer, P. D., Einwalter, L. A., Moninger, T. O., Rokhlina, T., Kern, J. A., Zabner, J., & Welsh, M. J. (2003) · Nature · doi:10.1038/nature01440 · Cited by 359
Rakha, E. A., Boyce, R. W. G., Abd El-Rehim, D., Kurien, T., Green, A. R., Paish, E. C., Robertson, J. F. R., & Ellis, I. O. (2005) · Modern Pathology · doi:10.1038/modpathol.3800445 · Cited by 350
Schroeder, J. A., Thompson, M. C., Gardner, M. M., & Gendler, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011248200 · Cited by 346
Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis
Landis, M. W., Pawlyk, B. S., Li, T., Sicinski, P., & Hinds, P. W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.019 · Cited by 329
Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents
Ren, J., Agata, N., Chen, D., Li, Y., Yu, W.-H., Huang, L., Raina, D., Chen, W., Kharbanda, S., & Kufe, D. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00020-0 · Cited by 325
Self-citationInteraction of the DF3/MUC1 Breast Carcinoma-associated Antigen and β-Catenin in Cell Adhesion
Yamamoto, M., Bharti, A., Li, Y., & Kufe, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12492 · Cited by 308
Self-citationIsolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen.
Siddiqui, J., Abe, M., Hayes, D., Shani, E., Yunis, E., & Kufe, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2320 · Cited by 308
Self-citationWnt signalling: variety at the core
Hoppler, S., & Kavanagh, C. L. (2007) · Journal of Cell Science · doi:10.1242/jcs.03363 · Cited by 279
Cell-associated episialin is a complex containing two proteins derived from a common precursor.
Ligtenberg, M. J., Kruijshaar, L., Buijs, F., van Meijer, M., Litvinov, S. V., & Hilkens, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42677-4 · Cited by 275
Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin
Macao, B., Johansson, D. G. A., Hansson, G. C., & Härd, T. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1035 · Cited by 265
Li, Q., Kuwahara, H., Yin, L., Li, Y., Ren, J., Yu, W.-H., Carraway, K. L., & Kufe, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100359200 · Cited by 257
Self-citationLi, Y., Bharti, A., Chen, D., Gong, J., & Kufe, D. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7216 · Cited by 241
Self-citationThe importance of MUC1 cellular localization in patients with breast carcinoma
Rahn, J. J., Dabbagh, L., Pasdar, M., & Hugh, J. C. (2001) · Cancer · Cited by 240
Huang, L., Chen, D., Liu, D., Yin, L., Kharbanda, S., & Kufe, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2474 · Cited by 230
Self-citationGulley, J. L., Arlen, P. M., Tsang, K.-Y., Yokokawa, J., Palena, C., Poole, D. J., Remondo, C., Cereda, V., Jones, J. L., Pazdur, M. P., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0126 · Cited by 228
Li, Y., Kuwahara, H., Ren, J., Wen, G., & Kufe, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000754200 · Cited by 226
Self-citationDetermination of the prognostic value of cyclin D1 overexpression in breast cancer.
McIntosh, G. G., Anderson, J. J., Milton, I. D., Steward, M., Parr, A., Thomas, M. D., Henry, J. A., Angus, B., Lennard, T. W. J., & Horne, C. H. W. (1995) · PubMed · Cited by 214
Hayes, D. F., Sekine, H., Ohno, T., Abe, M., Keefe, K., & Kufe, D. W. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111875 · Cited by 210
Self-citationβ-Catenin and Tcfs in Mammary Development and Cancer
Hatsell, S., Rowlands, T., Hiremath, M., & Cowin, P. (2003) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1025944723047 · Cited by 209
The MUC1 SEA Module Is a Self-cleaving Domain
Levitin, F., Stern, O., Weiss, M., Gil-Henn, C., Ziv, R., Prokocimer, Z., Smorodinsky, N. I., Rubinstein, D. B., & Wreschner, D. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506047200 · Cited by 204
Human DF3/MUC1 carcinoma-associated protein functions as an oncogene
Li, Y., Liu, D. H., Chen, D., Kharbanda, S. M., & Kufe, D. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206732 · Cited by 196
Self-citationAssociation of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein.
Pandey, P., Kharbanda, S. M., & Kufe, D. W. (1995) · PubMed · Cited by 189
Self-citationMUC1-C Oncoprotein Functions as a Direct Activator of the Nuclear Factor-κB p65 Transcription Factor
Ahmad, R., Raina, D., Joshi, M. D., Kawano, T., Ren, J., Kharbanda, S., & Kufe, D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0523 · Cited by 189
Self-citationRole of the Sec61 Translocon in EGF Receptor Trafficking to the Nucleus and Gene Expression
Liao, H.-J., & Carpenter, G. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-09-0802 · Cited by 187
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Wei, X., Xu, H., & Kufe, D. (2006) · Molecular Cell · doi:10.1016/j.molcel.2005.11.030 · Cited by 186
Self-citationThe MUC1 and Galectin-3 Oncoproteins Function in a MicroRNA-Dependent Regulatory Loop
Ramasamy, S., Duraisamy, S., Barbashov, S., Kawano, T., Kharbanda, S., & Kufe, D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.031 · Cited by 180
Self-citationDependence on the MUC1-C Oncoprotein in Non–Small Cell Lung Cancer Cells
Raina, D., Kosugi, M., Ahmad, R., Panchamoorthy, G., Rajabi, H., Alam, M., Shimamura, T., Shapiro, G. I., Supko, J., Kharbanda, S., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-1050 · Cited by 178
Self-citationAmplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer
Dickson, C., Fantl, V., Gillett, C., Brookes, S., Bartek, J., Smith, R., Fisher, C., Barnes, D., & Peters, G. (1995) · Cancer Letters · doi:10.1016/0304-3835(94)03676-a · Cited by 176
MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signalling
Ahmad, R., Raina, D., Trivedi, V., Ren, J., Rajabi, H., Kharbanda, S., & Kufe, D. (2007) · Nature Cell Biology · doi:10.1038/ncb1661 · Cited by 174
Self-citationMUC1 alters β-catenin-dependent tumor formation and promotes cellular invasion
Schroeder, J. A., Adriance, M. C., Thompson, M. C., Camenisch, T. D., & Gendler, S. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206291 · Cited by 173
Raina, D., Kharbanda, S., & Kufe, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310538200 · Cited by 170
Self-citationNuclear Association of the Cytoplasmic Tail of MUC1 and β-Catenin
Wen, Y., Caffrey, T. C., Wheelock, M. J., Johnson, K. R., & Hollingsworth, M. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304333200 · Cited by 164
MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation
Schroeder, J. A., Masri, A. A., Adriance, M. C., Tessier, J. C., Kotlarczyk, K. L., Thompson, M. C., & Gendler, S. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207713 · Cited by 152
Protein Kinase C δ Regulates Function of the DF3/MUC1 Carcinoma Antigen in β-Catenin Signaling
Ren, J., Li, Y., & Kufe, D. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200436200 · Cited by 149
Self-citationRaina, D. B., Ahmad, R., Joshi, M. D., Li, Y., Wu, Z., Kawano, T., Vasir, B., Avigan, D., Kharbanda, S. M., & Kufe, D. W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0854 · Cited by 145
Self-citationGaemers, I. C., Vos, H. L., Volders, H. H., van der Valk, S. W., & Hilkens, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009449200 · Cited by 143
Nuclear Import of the MUC1-C Oncoprotein Is Mediated by Nucleoporin Nup62
Leng, Y., Cao, C., Ren, J., Huang, L. H., Chen, D., Ito, M., & Kufe, D. W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703222200 · Cited by 136
Self-citationMUC1 regulates nuclear localization and function of the epidermal growth factor receptor
Bitler, B. G., Goverdhan, A., & Schroeder, J. A. (2010) · Journal of Cell Science · doi:10.1242/jcs.062661 · Cited by 136
Mohebtash, M., Tsang, K.-Y., Madan, R. A., Huen, N., Poole, D. J., Jochéms, C., Jones, J. L., Ferrara, T. A., Heery, C. R., Arlen, P. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0649 · Cited by 131
Ren, J., Bharti, A. K., Raina, D. B., Chen, W., Ahmad, R., & Kufe, D. W. (2005) · Oncogene · doi:10.1038/sj.onc.1209012 · Cited by 128
Self-citationPitroda, S., Khodarev, N., Beckett, M., Kufe, D., & Weichselbaum, R. (2009) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0812029106 · Cited by 123
Self-citationAnalysis of the tissue-specific promoter of the MUC1 gene
Kovarik, A., Peat, N., Wilson, D. B., et al. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98432-2 · Cited by 122
Merlin, J., Stechly, L., de Beauce, S., Monté, D., Leteurtre, E., SEUNINGEN, I. V., Huet, G., & Pigny, P. (2011) · Oncogene · doi:10.1038/onc.2010.631 · Cited by 116
Abe, M., & Kufe, D. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.282 · Cited by 112
Self-citationFunctional targeting of the MUC1 oncogene in human cancers
Kufe, D. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.13.8844 · Cited by 111
Self-citationSingh, P. K., Wen, Y., Swanson, B. J., Shanmugam, K., Kazlauskas, A., Cerny, R. L., Gendler, S. J., & Hollingsworth, M. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4647 · Cited by 107
MUC1-C Oncoprotein Promotes STAT3 Activation in an Autoinductive Regulatory Loop
Ahmad, R., Rajabi, H. N., Kosugi, M., Joshi, M. D., Alam, M., Vasir, B., Kawano, T., Kharbanda, S. M., & Kufe, D. W. (2011) · Science Signaling · doi:10.1126/scisignal.2001426 · Cited by 106
Self-citationFrequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas.
Merlo, G. R., Siddiqui, J., Cropp, C. S., et al. (1989) · PubMed · Cited by 104
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer
Khodarev, N. N., Ahmad, R., Rajabi, H. N., Pitroda, S. P., Kufe, T., McClary, C., Joshi, M. D., MacDermed, D. M., Weichselbaum, R., & Kufe, D. W. (2009) · Oncogene · doi:10.1038/onc.2009.391 · Cited by 103
Self-citationMUC1 Oncoprotein Functions in Activation of Fibroblast Growth Factor Receptor Signaling
Ren, J., Raina, D. B., Chen, W., Li, G., Huang, L. H., & Kufe, D. W. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0204 · Cited by 94
Self-citationLi, Y., Yu, W., Ren, J., Chen, W., Huang, L. H., Kharbanda, S. M., Loda, M. F., & Kufe, D. W. (2003) · PubMed · Cited by 94
Self-citationPhosphorylation of MUC1 by Met Modulates Interaction with p53 and MMP1 Expression
Singh, P. K., Behrens, M. E., Eggers, J. P., Cerny, R. L., Bailey, J. M., Shanmugam, K., Gendler, S. J., Bennett, E., & Hollingsworth, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805036200 · Cited by 90
Lagow, E. L., & Carson, D. D. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10261 · Cited by 90
Mucin 1 Oncoprotein Expression Is Suppressed by the miR-125b Oncomir
Rajabi, H. N., Jin, C., Ahmad, R., McClary, A. C., Joshi, M. D., & Kufe, D. W. (2010) · Genes & Cancer · doi:10.1177/1947601909357933 · Cited by 90
Self-citationHe, C., Hobert, M. E., Friend, L., & Carlin, C. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104646200 · Cited by 87
Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway
Woo, J. K., Choi, Y. K., Oh, S.-H., Jeong, J.-H., Choi, D.-H., Seo, H.-S., & Kim, C.-W. (2011) · Oncogene · doi:10.1038/onc.2011.410 · Cited by 86
Rajabi, H. N., Ahmad, R., Jin, C., Kosugi, M., Alam, M., Joshi, M. D., & Kufe, D. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.323311 · Cited by 81
Self-citationZaretsky, J. Z., Barnea, I., Aylon, Y., Gorivodsky, M., Wreschner, D. H., & Keydar, I. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-57 · Cited by 80
MUC1-C Oncoprotein Regulates Glycolysis and Pyruvate Kinase m2 Activity in Cancer Cells
Kosugi, M., Ahmad, R., Alam, M., Uchida, Y., & Kufe, D. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028234 · Cited by 79
Self-citationInvolvement of the MAP kinase ERK2 in MUC1 mucin signaling
Meerzaman, D. M., Shapiro, P. S., & Kim, K. C. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.1.l86 · Cited by 78
Ibrahim, N. K., Yariz, K. O., Bondarenko, I., Manikhas, A., Семиглазов, В. Ф., Alyasova, A. V., Komisarenko, V., Shparyk, Y. V., Murray, J. L., Jones, D. A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1151 · Cited by 75
Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells
Kufe, D. W. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1308 · Cited by 75
Self-citationRecycling of MUC1 Is Dependent on Its Palmitoylation
Kinlough, C. L., McMahan, R. J., Poland, P. A., Bruns, J. B., Harkleroad, K. L., Stremple, R. J., Kashlan, O. B., Weixel, K. M., Weisz, O. A., & Hughey, R. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512996200 · Cited by 70
MUC1 oncoprotein is a druggable target in human prostate cancer cells
Joshi, M. D., Ahmad, R., Li, Y., Raina, D. B., Rajabi, H. N., Bubley, G. J., Kharbanda, S. M., & Kufe, D. W. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0646 · Cited by 70
Self-citationGopal, U., Jayanthi, V., Devaraj, N., & Devaraj, H. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20311 · Cited by 68
MUC1 Membrane Trafficking Is Modulated by Multiple Interactions
Kinlough, C. L., Poland, P. A., Bruns, J. B., Harkleroad, K. L., & Hughey, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409360200 · Cited by 65
miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death
Kufe (2010) · International Journal of Oncology · doi:10.3892/ijo_00000653 · Cited by 64
Horn, G., Gaziel, A., Wreschner, D. H., Smorodinsky, N. I., & Ehrlich, M. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.02.011 · Cited by 54
Kato, K., Lu, W., Kai, H., & Kim, K. C. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00423.2006 · Cited by 52
Transforming Growth Factor α–Dependent Cancer Progression Is Modulated by Muc1
Pochampalli, M. R., Bitler, B. G., & Schroeder, J. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4518 · Cited by 52
MUC1‐C oncoprotein confers androgen‐independent growth of human prostate cancer cells
Rajabi, H. N., Ahmad, R., Jin, C., Joshi, M. D., Guha, M., Alam, M., Kharbanda, S. M., & Kufe, D. W. (2012) · The Prostate · doi:10.1002/pros.22519 · Cited by 51
Self-citationKondo, S., Yoshizaki, T., Wakisaka, N., Horikawa, T., Murono, S., Jang, K. L., Joab, I., Furukawa, M., & Pagano, J. S. (2006) · Journal of Virology · doi:10.1128/jvi.02222-06 · Cited by 50
Arlen, P. M., Pazdur, M. P., Skarupa, L., Rauckhorst, M., & Gulley, J. L. (2006) · Clinical Breast Cancer · doi:10.3816/cbc.2006.n.032 · Cited by 40
Li, Y., Yi, H., Yao, Y., Liao, X., Xie, Y., Yang, J., Yan, Z., Wang, L., Lu, S., Kuang, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019102 · Cited by 21
Cited by
Srinivasarao, M., & Low, P. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00013 · Cited by 605
STAT3 Target Genes Relevant to Human Cancers
Carpenter, R., & Lo, H.-W. (2014) · Cancers · doi:10.3390/cancers6020897 · Cited by 511
McLean, M. H., & El-Omar, E. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.143 · Cited by 395
Regulation of PD-L1 Expression by NF-κB in Cancer
Antonangeli, F., Natalini, A., Garassino, M. C., Sica, A., Santoni, A., & Di Rosa, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584626 · Cited by 385
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
Kon, E., Ad-El, N., Hazan-Halevy, I., Stotsky-Oterin, L., & Peer, D. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00811-9 · Cited by 371
Metadata
- Authors
- Kufe, D. W.
- Venue
- Oncogene
- Published
- 2012-05-14
- Volume
- 32
- Issue
- 9
- Pages
- 1073-1081
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2034451570
- Cited by
- 437
- References
- 90
- FWCI
- 8.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.